PDCD1 and neoplasm: Many studies have investigated the role of programmed cell death 1 (PD1)/programmed death-ligand 1 (PD-L1) in immunosuppression and verified their ability to act as a prognostic biomarker for tumor progression or as a biomarker for predicting immune response.